Biotech startups that raised Series B in Israel
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Phytolon | Yoqne`am `illit | Series B | $23.6M | 2026-05-26 |
| Imagene AI | Tel Aviv | Series B | $23.0M | 2025-07-01 |
| CytoReason | Tel Aviv | Series B | $80.0M | 2024-07-17 |
| DOT Compliance | Ness Ziona | Series B | $17.5M | 2024-04-15 |
4 rows of the CSV in 5 of its 18 columns.
- The 26 biotech startups in Israel whose last round is Series B have raised $555.5M in total.
- 1 of them closed their most recent round in the last 12 months, $23.6M combined.
- The largest of those rounds is Phytolon's $23.6M Series B, dated May 2026.
- Health care is the most common other sector, with 22 companies (85%).
- 4% were founded in 2020 or later; the median founding year is 2014.
- The most common team size is 11 to 50 employees (56% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
4 of 26| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Phytolon | Phytolon supplies natural food colors of high quality at low cost. | Biotech | Yoqne`am `illit | Series B | $23.6M | 2026-05-26 | $43.7M | MassChallenge, Trendlines Group, Millenium Food-Tech | 11 to 50 | 2018 |
| CytoReason | CytoReason develops a cell-centered computational model of the human body to find patterns in biological data. | Artificial intelligence | Tel Aviv | Series B | $80.0M | 2024-07-17 | $100.0M | OurCrowd, Asymmetry Ventures, Pfizer | 101 to 250 | 2016 |
| DOT Compliance | DOT Compliance provides a ready-to-use cloud-based quality and compliance management solution for regulated industries. | Biotech | Ness Ziona | Series B | $17.5M | 2024-04-15 | Vertex Ventures, TPY Capital, Israel Growth Partners | 101 to 250 | 2007 | |
| Treato | Treato collects patient-written health experiences from blogs and forums to reveal patient opinions. | Artificial intelligence | Or Yehuda | Series B | $14.5M | 2013-04-23 | Western Technology Investment, OrbiMed, REV +1 | 11 to 50 | 2008 |
Table 1. Biotech startups that raised Series B in Israel: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 26.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Phytolon | Phytolon supplies natural food colors of high quality at low cost. | Biotech | Yoqne`am `illit | Series B | $23.6M | 2026-05-26 | $43.7M | MassChallenge, Trendlines Group, Millenium Food-Tech | 11 to 50 | 2018 |
Table 2. Biotech startups that raised Series B in Israel: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Millenium Food-Tech | Venture capital firm | Tel Aviv, Israel | 1 | 4% | 1 | Phytolon |
| 2 | MassChallenge | Startup accelerator | Boston, United States | 1 | 4% | 1 | Phytolon |
| 3 | Trendlines Group | Venture capital firm | Misgav, Israel | 1 | 4% | 1 | Phytolon |
| 4 | Blumberg Capital | Venture capital firm | San Francisco, United States | 1 | 4% | ||
| 5 | Asymmetry Ventures | Venture capital firm | San Francisco, United States | 1 | 4% | ||
| 6 | Pfizer | Corporate venture arm | New York, United States | 1 | 4% | ||
| 7 | OurCrowd | Venture capital firm | Jerusalem, Israel | 1 | 4% | ||
| 8 | TPY Capital | Venture capital firm | Tel Aviv, Israel | 1 | 4% | ||
| 9 | Vertex Ventures | Venture capital firm | Singapore | 1 | 4% | ||
| 10 | Israel Growth Partners | Private equity firm | Herzliya, Israel | 1 | 4% | ||
| 11 | Western Technology Investment | Venture capital firm | Portola Valley, United States | 1 | 4% | ||
| 12 | REV | Corporate venture arm | London, United Kingdom | 1 | 4% | ||
| 13 | New Leaf Venture Partners | Venture capital firm | New York, United States | 1 | 4% | ||
| 14 | OrbiMed | Private equity firm | New York, United States | 1 | 4% |
Table 3. Biotech startups that raised Series B in Israel: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 22 | 85% | $511.8M |
| Software | 6 | 23% | $144.5M |
| Artificial intelligence | 4 | 15% | $144.5M |
| Hardware | 3 | 12% | |
| Cybersecurity | 1 | 4% | |
| Education | 1 | 4% | $3.4M |
Table 4. Biotech startups that raised Series B in Israel by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 26 | 100% | $17.5M |
Table 5. Biotech startups that raised Series B in Israel by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Tel Aviv | 7 | 27% |
| Or Yehuda | 3 | 12% |
| Ness Ziona | 3 | 12% |
| Jerusalem | 2 | 8% |
| Herzliya | 2 | 8% |
| Yoqne`am `illit | 1 | 4% |
| Haifa | 1 | 4% |
| Rehovot | 1 | 4% |
| Yavne | 1 | 4% |
| Ra'anana | 1 | 4% |
| Ofakim | 1 | 4% |
| Misgav | 1 | 4% |
Table 6. Biotech startups that raised Series B in Israel by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| May 2026 | 1 | 100% | $23.6M |
Table 7. Biotech startups that raised Series B in Israel: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 1 | 4% | $23.6M |
| 2025 | 3 | 12% | $68.0M |
| 2024 | 3 | 12% | $97.5M |
| 2023 | 1 | 4% | $14.0M |
| 2022 | 2 | 8% | $120.0M |
| 2021 | 4 | 15% | $400.8M |
Table 8. Biotech startups that raised Series B in Israel by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 1 | 4% |
| 2015 to 2019 | 11 | 42% |
| 2010 to 2014 | 3 | 12% |
| Before 2010 | 11 | 42% |
Table 9. Biotech startups that raised Series B in Israel by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 6 | 24% |
| 11 to 50 | 14 | 56% |
| 51 to 100 | 3 | 12% |
| 101 to 250 | 2 | 8% |
Table 10. Biotech startups that raised Series B in Israel by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series B and its headquarters is in Israel. On 16 November 2026 that is 26 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 4 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 26 rows: 3 have no round amount, 0 no city and 8 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Israel whose last round is Series B are on the list?
- 26, in the file dated 16 November 2026. 1 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 26 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.